30.50 USD
+0.11
0.36%
Updated Aug 26, 1:19 PM EDT
1 day
0.36%
5 days
8.93%
1 month
12.42%
3 months
22.24%
6 months
12.96%
Year to date
21.08%
1 year
17.26%
5 years
-1.49%
10 years
21.61%
 

About: Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.

Employees: 2,082

0
Funds holding %
of 7,431 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 2 (+1) [Q2]

83% more call options, than puts

Call options by funds: $5.77M | Put options by funds: $3.16M

44% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 62

14% more capital invested

Capital invested by funds: $1.44B [Q1] → $1.64B (+$199M) [Q2]

6% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 35

0.96% more ownership

Funds ownership: 95.85% [Q1] → 96.81% (+0.96%) [Q2]

0% less funds holding

Funds holding: 219 [Q1] → 218 (-1) [Q2]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$34
11%
upside
Avg. target
$35
14%
upside
High target
$35
15%
upside

3 analyst ratings

positive
100%
neutral
0%
negative
0%
Keybanc
Aleksey Yefremov
15%upside
$35
Overweight
Maintained
14 Jul 2025
Truist Securities
Jailendra Singh
15%upside
$35
Buy
Maintained
29 May 2025
Canaccord Genuity
Richard Close
11%upside
$34
Buy
Maintained
29 May 2025

Financial journalist opinion

Based on 5 articles about PHR published over the past 30 days

Neutral
Business Wire
5 days ago
Phreesia and Sesame Workshop Announce 5-Year Collaboration to Improve the Health of Millions of Children Through the Power of Sesame Street
ALL-REMOTE COMPANY/WILMINGTON, Del. & NEW YORK--(BUSINESS WIRE)--Phreesia and Sesame Workshop announce a collaboration to educate and engage parents and caregivers of young children at the point of care.
Phreesia and Sesame Workshop Announce 5-Year Collaboration to Improve the Health of Millions of Children Through the Power of Sesame Street
Positive
Seeking Alpha
1 week ago
Why Phreesia Feels Like The Right Bet In Healthcare Tech
Phreesia is on track to meet FY26 revenue targets, driven by steady client growth and strong average revenue per client. Margins are improving, with adjusted EBITDA trending toward high teens and free cash flow beginning to emerge, supporting long-term leverage. Valuation is balanced at 3.3x forward EV/S, but real upside depends on sustained margin expansion and cash flow conversion.
Why Phreesia Feels Like The Right Bet In Healthcare Tech
Neutral
Business Wire
1 week ago
Phreesia Named to the 2025 Capterra Shortlist for Patient Engagement and Medical Scheduling
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been named to the 2025 Capterra Shortlist in the Patient Engagement and Medical Scheduling categories.
Phreesia Named to the 2025 Capterra Shortlist for Patient Engagement and Medical Scheduling
Neutral
Business Wire
2 weeks ago
Phreesia Sets Release Date for Fiscal Second Quarter 2026 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal second quarter 2026 financial results after the close of market trading on Thursday, Sept. 4, 2025.
Phreesia Sets Release Date for Fiscal Second Quarter 2026 Results
Neutral
Business Wire
3 weeks ago
New Research Illustrates Gaps in COPD Care and the Need for Better Patient-Provider Communication
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--New research from the COPD Foundation and Phreesia shows conversations with healthcare providers can play a critical role in helping COPD patients.
New Research Illustrates Gaps in COPD Care and the Need for Better Patient-Provider Communication
Positive
The Motley Fool
1 month ago
3 Red-Hot Growth Stocks to Buy in 2025
Growth stocks are one of the best ways for you to grow your portfolio and build a comfortable nest egg for retirement. However, you need to choose such stocks carefully to ensure that you pick gems and not duds.
3 Red-Hot Growth Stocks to Buy in 2025
Positive
Zacks Investment Research
1 month ago
All You Need to Know About Phreesia (PHR) Rating Upgrade to Buy
Phreesia (PHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
All You Need to Know About Phreesia (PHR) Rating Upgrade to Buy
Neutral
Business Wire
1 month ago
Phreesia Named in Black Book Research's List of 2025's Top-Rated Vendors for Patient Access and Front-End Management Solutions in Revenue Cycle Management
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been named to Black Book Research's 2025 list of Top-Rated Vendors for Patient Access and Front-End Management Solutions in RCM.
Phreesia Named in Black Book Research's List of 2025's Top-Rated Vendors for Patient Access and Front-End Management Solutions in Revenue Cycle Management
Neutral
Business Wire
2 months ago
Becker's Names Phreesia's Kristin Roberts as one of 2025's 100 Women in Health IT to Know
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announces that Kristin Roberts has been named in Becker's Hospital Review's 2025 list of the 100 Women in Health IT to Know.
Becker's Names Phreesia's Kristin Roberts as one of 2025's 100 Women in Health IT to Know
Positive
Zacks Investment Research
2 months ago
Phreesia (PHR) Upgraded to Buy: What Does It Mean for the Stock?
Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Phreesia (PHR) Upgraded to Buy: What Does It Mean for the Stock?
Charts implemented using Lightweight Charts™